Principal Investigator
Frances Valdes
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20221297
Clinical Trial Summary
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients with Metastatic (Stage IV) Breast Cancer: A Phase 2 Randomized, Open-Label Study
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Breast Cancer
Contact Information
Phone Number
+1 (305) 2434624